The integration into the national procurement framework follows extensive clinical success in UK settings. Peripheral IV therapy remains a high-frequency procedure in NHS hospitals, yet manual monitoring often fails to catch tissue damage before it escalates. The ivWatch system utilizes optical sensing and predictive algorithms to identify fluid leakage into surrounding tissue, allowing clinicians to intervene long before visual symptoms appear.

Andrew Barton, a Nurse Consultant at Frimley Health NHS Foundation Trust and Chairman of the National Infusion and Vascular Access Society, led the initial implementation of the technology. His trials demonstrated that the system detected 100% of infiltration events before they were visible to staff. Following two years of deployment without a single extravasation injury in his units, Barton’s work received the HSJ Patient Safety Pilot Program of the Year award. This procurement milestone enables broader adoption across acute and specialty care units, including oncology and pediatric departments, as the NHS seeks to lower avoidable hospital costs and improve long-term patient outcomes.